Showing results (121-130 of 202) with videos related to

Sort By:
Pageof 21
International Journal of Cancer|August 4, 1998
Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumorsG Ferrandina, G Almadori, N Maggiano, et al.
Journal of the National Cancer Institute|October 18, 2001
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) miceC Colussi, S Fiumicino, A Giuliani, et al.
The Journal of Pathology|April 21, 1999
Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumourE Di Carlo, A Modesti, A Coletti, et al.
Scandinavian Journal of Immunology|April 27, 2002
Enhanced inhibition of tumour growth and metastasis, and induction of antitumour immunity by IL-2-IgG2b fusion proteinV Budagian, P Nanni, P L Lollini, et al.
Gene Therapy|January 13, 1998
Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccinesL Santodonato, G D'Agostino, S M Santini, et al.
American Journal of Industrial Medicine|April 1, 1995
Malignant mesothelioma in thermoelectric power plant workers in ItalyP Crosignani, F Forastiere, G Petrelli, et al.
Cancer Gene Therapy|February 26, 1998
Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 geneM V Corrias, S Basso, R Meazza, et al.
The Journal of Pathology|June 22, 2000
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude miceE Di Carlo, R Meazza, S Basso, et al.
International Journal of Immunopathology and Pharmacology|June 3, 2004
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitisT Pannellini, M Iezzi, E Di Carlo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1996
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alphaP Musiani, A Allione, A Modica, et al.
Pageof 21